Medeon Biodesign has announced the successful completion of its first-in-human studies for its XPro suture-mediated vascular closure device, targeting to close 8F-21F femoral access sites.
There have been five human studies using the intra-arterial route for delivery of a range of different bone marrow-derived stem cells. All have shown that this approach is feasible and safe, including in the early phase after ischaemic stroke, writes Soma Banerjee, London, UK.
Venous interventions, particularly stenting, thrombolysis and thrombectomy are achieving ever-greater significance in the interventional world, Gerard O’Sullivan, Department of Radiology, University Hospital Galway, Ireland, told Interventional News at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE, 26– 30 September, Lisbon, Portugal).
Hansen has announced that it has accelerated the development of the latest addition to the Magellan Robotic System portfolio, the Magellan 3F robotic microcatheter. The development of this important product line expansion has surpassed key milestones and is moving toward the final stages of the development process.
People with diabetes may be harbouring advanced vascular disease that could increase their risk of stroke, according to new research being presented next week at the annual meeting of the Radiological Society of North America (RSNA). The findings suggest that arterial imaging with 3D MRI could be useful in helping to determine stroke risk among diabetics.
Researchers have developed software for the Microsoft Kinect gaming console that measures body part thickness and checks for motion, positioning and beam adjustment immediately before X-ray imaging, according to a feasibility study presented at the annual meeting of the Radiological Society of North America (RSNA).
Jafar Golzarian, a professor of interventional radiology, University of Minnesota, Minneapolis, USA, founded EmboMedics in 2012 and serves as its chief medical officer. He tells Interventional News about the factors driving an interest in resorbable embolics.
Maurizio Grosso, director, Radiology, S Croce Hospital, Cuneo, Italy, tells Interventional News about the preliminary data being collected in the Italian prostate artery embolization registry and the encouraging results being obtained with the new treatment option.
On 7 September 1990, a 70-year-old man with severe chronic obstructive pulmonary disease and severe back pain caused by a 6cm abdominal aortic aneurysm underwent the first successful endovascular aneurysm repair (EVAR) in the Western world. The case by Juan C Parodi and Julio Palmaz became the first widely known endovascular repair of the aorta and was described the following year in the Annals of Vascular Surgery. On the 25th anniversary of that landmark case, we dedicate these pages to some of the EVAR pioneers.
New clinical data in interventional treatments for aortic and peripheral vascular diseases have been revealed by Medtronic during a late-breaking trial session at Vascular Interventional Advances (VIVA) 2015.
The first patient has been enrolled in the US ROADSTER 2 post approval study at Greenville Memorial Hospital in Greenville, USA.
Endologix and TriVascular announced on 26 October that they have entered into a definitive merger agreement under which Endologix and TriVascular will combine in a stock and cash transaction. The transaction is valued at US$9.10 per TriVascular share, or a total of approximately US$211 million, based on Endologix’s closing stock price of US$13.81 per share on 23 October 2015.
It is safe and effective to place biodegradable biliary stents to treat benign biliary strictures. This treatment compares favourably with standard techniques in terms of patients’ quality of life and avoids the need for repeated invasive procedures, found a study recently presented at the CIRSE conference (26–30 September, Lisbon, Portugal).
Merit has announced that it has signed an exclusive worldwide distribution agreement (excluding Japan) with Sumitomo Bakelite to distribute a steerable microcatheter under the proposed trademark of Swiftninja.
Bob Abraham, ABK Biomedical, Halifax, Canada, presented computed tomography and magnetic resonance imaging characteristics of novel radiopaque yttrium-strontium-gallium–silicate oxide glass microspheres at CIRSE. These beads, called Occlu90Y, are potential materials for radioembolization.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos